Focused radiation vs. observation for rare cancer that has spread
Part of Cancer clinical trials.
This study is testing whether focused radiation therapy (called SBRT) can control cancer that has spread to a few places in patients with a rare cancer called adenoid cystic carcinoma. It compares this treatment with watching the cancer closely without active treatment, to see which is better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of adenoid cystic carcinoma, a rare cancer that often starts in the salivary glands.
- You must have 1 to 5 areas of cancer spread (metastases) that can be safely treated with focused radiation.
- You should be generally able to care for yourself and perform daily activities (ECOG score 0-2).
- The original tumor must be controlled or treatable with surgery or radiation.
- You cannot have more than 5 active metastatic spots, an urgent medical condition, or uncontrolled other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether focused radiation (SBRT) can help control adenoid cystic carcinoma that has spread to a small number of places (oligometastatic disease). If you qualify, the study will treat up to 1–5 metastatic spots that doctors think can be safely targeted, to help control the cancer locally.
This observational study follows people with rare solid tumors and a limited number of metastases treated with a focused radiation technique (SBRT). Doctors want to see outcomes after using a strong, curative-intent radiation dose to all active spots.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial tests whether giving immune-supporting cells (lymphocytes) alongside focused radiation (SBRT) can help control limited cancer spread. People with 1 to 5 small tumors that can all be radiated within two weeks may be eligible.
This trial studies how targeted radiation (SBRT) affects cancer biology and immune cells in people with colon cancer that has spread only to a small number of lung nodules. Your tumor tissue will be analyzed to see what changes after treatment.
This trial tests whether targeted radiation can control a few growing spots of breast cancer while the rest of the cancer stays stable on your current treatment. It aims to delay the need to switch to a new therapy.
Hear when a new Adenoid Cystic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.